Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-03-06 @ 1:21 AM
Study NCT ID:
NCT00620594
Status:
COMPLETED
Last Update Posted:
2020-12-09
First Post:
2008-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2013-01-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-08
First Submit QC Date:
None
Study First Post Date:
2008-02-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-06
Last Update Post Date:
2020-12-09
Last Update Post Date Type:
ACTUAL